Enable JavaScript to visit this website.

What is XELJANZ/XELJANZ XR?

XELJANZ/XELJANZ XR (tofacitinib) is a prescription medicine called a Janus kinase (JAK) inhibitor used to treat:

  • Adults with moderately to severely active rheumatoid arthritis in whom methotrexate did not work well.
  • Adults with active psoriatic arthritis in whom methotrexate or other similar medicines called nonbiologic disease-modifying antirheumatic drugs (DMARDs) did not work well.

XELJANZ is also used to treat:

  • Adults with moderately to severely active ulcerative colitis.

It is not known if XELJANZ/XELJANZ XR is safe and effective in children or in people with hepatitis B or C.

XELJANZ/XELJANZ XR is not recommended for people with severe liver problems.

If you no longer wish to receive information or updates about XELJANZ, please enter your email address below and we will remove you from our contact list.

*REQUIRED FIELD

For more information or assistance, please Contact Us.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.